يعرض 61 - 80 نتائج من 177,655 نتيجة بحث عن '(( i large decrease ) OR ((( a large increases ) OR ( a ((a decrease) OR (nn decrease)) ))))', وقت الاستعلام: 3.65s تنقيح النتائج
  1. 61
  2. 62
  3. 63

    Spatial stability is decreased in APP/PS1 mice in both dCA1 and vCA1. حسب Udaysankar Chockanathan (18510288)

    منشور في 2024
    "…<p>(A) In dCA1, stability score was significantly decreased in APP/PS1 mice relative to C57BL/6 mice (mean ± std: C57BL/6 = -0.009 ± 0.292, APP/PS1 = -0.1845 ± 0.256, p < 10<sup>−6</sup>, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 295 units from 5 recording sessions, n<sub>APP/PS1</sub> = 167 units from 4 recording sessions). …"
  4. 64

    Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice. حسب Udaysankar Chockanathan (18510288)

    منشور في 2024
    "…<p>(A) Spiking activity of representative neurons (black points) overlaid with animal trajectories on the virtual track (gray lines). …"
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69

    Spatial information of excitatory neurons in APP/PS1 mice are decreased in dCA1 and vCA1. حسب Udaysankar Chockanathan (18510288)

    منشور في 2024
    "…<p>(A) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.134 ± 0.050, APP/PS1 = 0.132 ± 0.054, p < 0.01, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 229 units from 5 recording sessions, n<sub>APP/PS1</sub> = 124 units from 4 recording sessions). …"
  10. 70
  11. 71
  12. 72

    Data Sheet 1_Early caffeine therapy decreases bronchopulmonary dysplasia but might increase mortality in preterm infants? a systematic review and meta-analysis.docx حسب Juan Ma (417126)

    منشور في 2025
    "…</p>Conclusions<p>Early caffeine therapy may reduce BPD incidence but increase mortality risk in infants. More large-scale, prospective studies are needed to further evaluate the efficacy of early vs. late caffeine therapy for BPD.…"
  13. 73

    Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  14. 74

    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  15. 75

    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  16. 76

    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  17. 77

    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

    منشور في 2022
    "…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"
  18. 78
  19. 79
  20. 80